- Home
- ALXO vs GDO Comparison
ALXO vs GDO Comparison
Compare ALXO & GDO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALXO
- GDO
- Stock Information
- Founded
- ALXO 2015
- GDO 2009
- Country
- ALXO United States
- GDO United States
- Employees
- ALXO N/A
- GDO N/A
- Industry
- ALXO Biotechnology: Pharmaceutical Preparations
- GDO Finance Companies
- Sector
- ALXO Health Care
- GDO Finance
- Exchange
- ALXO Nasdaq
- GDO Nasdaq
- Market Cap
- ALXO 76.5M
- GDO 86.2M
- IPO Year
- ALXO 2020
- GDO N/A
- Fundamental
- Price
- ALXO $1.12
- GDO $11.37
- Analyst Decision
- ALXO Buy
- GDO
- Analyst Count
- ALXO 6
- GDO 0
- Target Price
- ALXO $6.64
- GDO N/A
- AVG Volume (30 Days)
- ALXO 769.2K
- GDO 39.4K
- Earning Date
- ALXO 03-06-2025
- GDO 01-01-0001
- Dividend Yield
- ALXO N/A
- GDO 9.81%
- EPS Growth
- ALXO N/A
- GDO N/A
- EPS
- ALXO N/A
- GDO N/A
- Revenue
- ALXO N/A
- GDO N/A
- Revenue This Year
- ALXO N/A
- GDO N/A
- Revenue Next Year
- ALXO N/A
- GDO N/A
- P/E Ratio
- ALXO N/A
- GDO N/A
- Revenue Growth
- ALXO N/A
- GDO N/A
- 52 Week Low
- ALXO $0.96
- GDO $11.21
- 52 Week High
- ALXO $17.83
- GDO $13.04
- Technical
- Relative Strength Index (RSI)
- ALXO 38.53
- GDO 50.77
- Support Level
- ALXO $1.00
- GDO $11.40
- Resistance Level
- ALXO $1.22
- GDO $11.52
- Average True Range (ATR)
- ALXO 0.09
- GDO 0.09
- MACD
- ALXO 0.00
- GDO 0.01
- Stochastic Oscillator
- ALXO 35.12
- GDO 51.52
About ALXO ALX Oncology Holdings Inc.
ALX Oncology Holdings Inc is a clinical-stage immuno-oncology company focused on helping patients fight cancer by developing a pipeline of product candidates based on expertise in protein engineering and oncology led by the CD47 blocker, evorpacept, currently in phase 1 and 2 clinical trials. Cancer cells leverage CD47, a cell surface protein, as a don't eat me signal to evade detection by the immune system. The company is developing a next-generation checkpoint inhibitor designed to have a high affinity for CD47 and to avoid the limitations caused by hematologic toxicities inherent in other CD47 blocking approaches.
About GDO Western Asset Global Corporate Defined Opportunity Fund Inc.
Western Asset Global Corp Defined Opp is a closed-end management investment company with a primary investment objective to provide current income. Its secondary objective is to seek capital appreciation. The Fund invests in the United States and foreign corporate fixed-income securities of varying maturities.